We are live on
!
Find out more
FAIM
Financial Advocates Investment Management Portfolio holdings
AUM
$178M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
-1.05%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.86%
5 Year Est. Return
+102.11%
10 Year Est. Return
–
AUM
$1.48B
AUM Growth
-$16.3M
(-1.1%)
Cap. Flow
-$2.38M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
18.91%
Holding
812
New
80
Increased
357
Reduced
266
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$38.8M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$17.6M |
| 3 |
iShares US Home Construction ETF
ITB
|
+$6.64M |
| 4 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$5.87M |
| 5 |
Novavax
NVAX
|
+$5.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$17.5M |
| 2 |
Shopify
SHOP
|
+$14.9M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$11.8M |
| 4 |
Parker-Hannifin
PH
|
+$6.83M |
| 5 |
Apple
AAPL
|
+$6.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.72% |
| 2 | Consumer Discretionary | 3.9% |
| 3 | Healthcare | 3.02% |
| 4 | Financials | 2.67% |
| 5 | Industrials | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
TG Therapeutics
TGTX
$7.58B
| – | – |
-5,423
| Closed | -$210K |
|
802
T-Mobile US
TMUS
$190B
| – | – |
-2,778
| Closed | -$344K |
|
803
Take-Two Interactive
TTWO
$45.4B
| – | – |
-2,510
| Closed | -$729K |
|
804
Upbound Group
UPBD
$1.11B
| – | – |
-4,581
| Closed | -$708K |
|
805
CALL
Valaris
VAL
$5.92B
| – | – |
-429
| Closed | -$202K |
|
806
Vanguard Financials ETF
VFH
$13.9B
| – | – |
-2,488
| Closed | -$225K |
|
807
ProShares VIX Short-Term Futures ETF
VIXY
$189M
| – | – |
-336
| Closed | -$341K |
|
808
CALL
Invesco Municipal Opportunity Trust
VMO
$662M
| – | – |
-82,017
| Closed | -$1.23M |
|
|
809
PUT
Vanguard Morningstar Value ETF
VTV
$193B
| – | – |
-94,823
| Closed | -$13M |
|
810
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| – | – |
-4,217
| Closed | -$329K |
|
|
SPLK
811
DELISTED
Splunk Inc
SPLK
| – | – |
-1,392
| Closed | -$201K |
|
Similar funds
OCBV
BAS
WAM
SAM
KAH
BI
CWM
AWM
Financial Advocates Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, Financial Advocates Investment Management held 812 positions worth $1.48B, down 1.1% from $1.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Financial Advocates Investment Management's Q3 2021 filing shows 80 new, 357 increased, 266 reduced and 73 closed positions. Its largest new stake was Vanguard Morningstar Value ETF: 126,301 shares worth $17.1M. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $17.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Financial Advocates Investment Management's largest Q3 2021 buy was Vanguard Morningstar Value ETF: 126,301 shares worth $17.1M.
- Financial Advocates Investment Management added most to Invesco QQQ Trust in Q3 2021, an estimated $38.8M increase.
- Financial Advocates Investment Management's biggest Q3 2021 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $17.5M.
- Financial Advocates Investment Management fully exited Invesco S&P 500 Pure Value ETF in Q3 2021, selling an estimated $4.24M.
- Financial Advocates Investment Management's ten largest holdings make up 19% of its $1.48B portfolio in Q3 2021.
- Financial Advocates Investment Management opened 80 new positions and closed 73 in Q3 2021.
- Financial Advocates Investment Management's portfolio value fell 1.1% quarter-over-quarter to $1.48B.
Based on Financial Advocates Investment Management's 13F filing for Q3 2021, filed 4 Nov 2021.